Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01315327 · ClinicalTrials.gov registry record · NA
Omega-3 Fatty Acids in Tourette's Disorder
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01315327 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 33 participants.
The verdict
NCT01315327, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study examines the safety and efficacy of omega-3 fatty acids (fish oil) for the treatment of Tourette's Disorder.
Interventions
- DRUG Omega-3 Fatty Acids
- DRUG Olive oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2003-05 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01315327
The ClinicalTrials.gov registry entry for NCT01315327 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Omega-3 Fatty Acids is the first listed.
NCT01315327 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01315327 about?
NCT01315327 is a clinical study titled "Omega-3 Fatty Acids in Tourette's Disorder". This study examines the safety and efficacy of omega-3 fatty acids (fish oil) for the treatment of Tourette's Disorder.
What is the current status of trial NCT01315327?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2003-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01315327?
The interventions under investigation include: Omega-3 Fatty Acids (DRUG), Olive oil (DRUG).
Who is sponsoring clinical trial NCT01315327?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.